Bimzelxs road to approval has not been without its trials
Later, it was effectively used in ulcerative colitis trials (phase II) without adverse effects [63,64]
In 2026, 5-Amino-1MQ research continues to expand, particularly into its long-term effects on metabolic health, cellular aging, and potential applications in neurodegenerative studies
These two peptides are gaining serious traction in the functional medicine and performance communitiesand for good reason
ISSLS prize winner: prevalence, determinants, and association of Schmorl nodes of the lumbar spine with disc degeneration: a population-based study of 2449 individuals
This is encouraging but limited - animal results do not always carry over to humans, and this is one study, not a body of evidence